Navigation Links
Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC
Date:5/14/2009

Technology to improve accuracy of ovarian cancer diagnosis

TAMPA, Fla., May 14 /PRNewswire/ -- Moffitt Cancer Center and Frantz BioMarkers, LLC have signed a license agreement on phospholipid biomarkers of ovarian cancer. Frantz BioMarkers, which has been granted exclusive worldwide rights to Moffitt's interests in the biomarkers, will pay initiation, developmental milestone and license maintenance fees, and royalties on sales. Moffitt and Frantz BioMarkers will collaborate on ovarian cancer biomarker research, combining use of these licensed markers with lipid markers developed independently by Frantz BioMarkers.

Each year, 26,000 women in the United States are diagnosed with ovarian cancer, and 16,000 die of the disease. There is no effective screening tool or method for accurate diagnosis without surgery. Even among symptomatic women, surgery is the only reliable way to distinguish between benign and malignant disease. It is estimated that up to 5 percent of women in the United States will undergo surgery for a suspected ovarian neoplasm. More than two-thirds of women undergoing surgery for suspected ovarian malignancy do not have cancer.

The only clinical blood biomarker available for diagnosis is CA125, which is unreliable, especially for accurate diagnosis at an early stage when a cure is feasible. Researchers at Moffitt and Frantz BioMarkers discovered that when CA125 is combined with selected phospholipids, the diagnostic accuracy for early stage ovarian cancer can significantly improve. More than 2,200 women donated blood samples for the research through the Tampa Bay Ovarian Cancer Coalition, a collaborative regional network. Frantz BioMarkers is developing these biomarkers into a clinical diagnostic test.

Co-inventors of the technology
'/>"/>

SOURCE Moffitt Cancer Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CMC, Moffitt Partner to Study Cancer
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. Novel Technology Breaks Through Cancer Pain
9. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
10. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/hxhwtv/asia_pacific ) has ... Market - Growth, Trends And Forecasts (2014 - 2019)" ... Asia Pacific market for Fluoroscopy ... 2014 to 2020 Fluoroscopy is the imaging ... of the interior of the body. The imaging team ...
(Date:5/27/2015)... senior marketing associate with the animal health division of Eli Lilly and ... setting in Bangkok, Thailand , will be among the ... respect and dignity is the guiding star for me and my fellow ... LillyPad blog . Donatelli and Lilly colleagues from ... , France , Ukraine ...
(Date:5/27/2015)... May 25, 2015 Research and Markets( ... "2015 Strategies in the Global Coagulation Testing ... This comprehensive seven-country report contains 650 pages, 150 ... and potential market entrants identify and evaluate business ... during the next five years. The ...
Breaking Medicine Technology:Asia Pacific Fluoroscopy Market Trends and Forecasts 2014 - 2019 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 3Global Coagulation Testing Market Strategies 2015 2Global Coagulation Testing Market Strategies 2015 3
... Trial to Further Assess Feasibility of Dose-sparing and ... Single-Dose Vaccination Against H5N1 Flu -, GAITHERSBURG, ... announced that it has received approval from the,Department of Health ... immunostimulant adjuvant patch for use with an injected H5N1,influenza vaccine. ...
... Show Glioblastoma Killing in the Presence of ... Dexamethasone in Mouse Tumor Model, SAN DIEGO, ... the presentation of positive data in a mouse,tumor model from its ... and usually fatal brain,cancer. The data were presented in the New ...
Cached Medicine Technology:Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 2Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 3Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 4Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting 2Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting 3Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting 4Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting 5
(Date:5/27/2015)... May 27, 2015 StatRad, a leading ... is pleased to introduce Mr. Chris E. Hafey as ... a proven track record of leading new development projects ... domain. He most recently served as the Chief Technology ... role of Chief Architect for Vital Images. , "I ...
(Date:5/27/2015)... 2015 Western University of Health Sciences’ ... historic firsts -- and one profound last. , The ... marked the first time the university surpassed more than ... Graduate College of Biomedical Sciences (GCBS) alumnus graduated from ... , The university’s fifth and final ceremony of its ...
(Date:5/27/2015)... Cleveland, OH (PRWEB) May 27, 2015 Ticket Down ... tickets . The Cavs have been super hot during the ... the Hawks by 30 points with a final score of 118-88. ... to the NBA Finals since 2006-2007 when they lost to ... this past summer, the chances of the Cavaliers making it to ...
(Date:5/27/2015)... May 27, 2015 The BBB Code ... service practices that enhance customer trust and confidence in ... for Trust, eight principles that summarize important elements of ... represents standards for business accreditation by BBB. Businesses based ... standards and complete application procedures will be accredited by ...
(Date:5/27/2015)... Homes are starting to supplant hospitals as focus of basic ... 2015 New York Times article. While Americans, in practice, tend ... of research have documented the risks of hospitalization for older ... safer for older patients and less costly than hospitals. ... and family members may worry whether a nursing home can ...
Breaking Medicine News(10 mins):Health News:StatRad Introduces Mr. Chris E. Hafey as Chief Technology Officer, and the Release of its Advanced Pure HTML5 DICOM Image Uploader 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 3Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 4Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 5Health News:Cavs NBA Finals Tickets: Ticket Down Slashes Ticket Prices on Cleveland Cavaliers 2015 NBA Finals Tickets at Quicken Loans Arena and Offers Valuable Promo Code 2Health News:Carson Energy Receives A+ Accredited Rating For 19 Consecutive Years 2Health News:BestNursingHomes.com Launches on National Senior Health and Fitness Day 2
... Researchers say elevated insulin production in patients is associated ... // is known as hyperinsulinemia. This association is seen ... other factors related to insulin. ,Researchers studied men ... measured the plasma concentration of C-peptide, which is an ...
... could be a new way to help prevent heart disease. ... high-density lipoprotein levels, also known as good cholesterol. Statins have ... disease. They are commonly used to lower low-density lipoprotein (LDL) ... a low level of good cholesterol. In fact, a low ...
... examine the initial mammogram immediately so any follow-up tests ... Between 5 percent and 11 percent of all screening ... for a follow-up mammogram. Many abnormal mammograms turn out ... a breast cancer diagnosis within one year. Even when ...
... Toronto conducted a study to examine whether current procedures ... antibiotics // unnecessarily. Out of an estimated 6.7 million ... Doctors also researched the use of throat cultures and ... who were prompted to seek medical help for their ...
... crews performing CPR on heart attack victims found they ... for by American Heart Association CPR standards.While the standards ... EMS personnel were delivering on average 37 -- essentially ... retrained to follow the guidelines, they gave about 22 ...
... 12 percent of children in the United States. Research has ... kids was seen more in children who watched more television ... kids watched television at ages 1 and 3. On average, ... watched about three and a half hours a week. ...
Cached Medicine News:
1 mm smooth 45 degrees angled jaws. Cross action serrated handle with polished finish....
14 mm oval solid lower plate and straight 9 mm serrated upper jaw. Locking thumb screw and serrated handle with polished finish....
Solid lower plate with outside width 28 mm. Open upper plate. Serrated handle with locking thumb screw and polished finish. Right....
Oval solid 17 mm wide lower plate. Open upper plate with inside dimensions 12 mm x 14 mm. Serrated handle with locking thumb screw and polished finish. Most popular size or model....
Medicine Products: